Epilepsy is a brain disorder that is marked by recurrent seizures. Seizures are episodes of disturbed brain function caused by abnormalities of the brain's electrical activity. There are many types of seizures.
Epilepsy can affect people of all ages but is most common in young children and older adults. Some types of epilepsy are inherited and are due to genetic factors. Other possible causes of epilepsy include brain injuries due to head trauma or oxygen deprivation at birth. In many cases, the cause of epilepsy is unknown (idiopathic.)
A health care provider will diagnose epilepsy based on a person's medical history, description of seizures, and various diagnostic tools. The most important diagnostic tool is the electroencephalogram (EEG), which allows providers to record and analyze brain waves. Imaging tests such as computed tomography (CT) and magnetic resonance imaging (MRI) may also be used.
The goal of epilepsy treatment is to control seizures. Many different types of anticonvulsant (anti-epileptic) drugs are available to treat epilepsy. Some people need only one drug, while others may need to take several drugs.
For people who have not been helped by medication, surgery or a neurostimulation device may be options. Dietary changes, such as the ketogenic diet, have shown promise in helping children with severe epilepsy.
Anti-epileptic drugs (AEDs) can cause many side effects. Pregnant women with epilepsy need to take special precautions, because some of these drugs (particularly valproate) can cause birth defects.
Epilepsy is a brain disorder involving repeated, spontaneous seizures of any type. There are different types of epilepsy but what they all share are recurrent seizures caused by an uncontrolled electrical discharge from nerve cells in the cerebral cortex. This part of the brain controls higher mental functions, general movement and sensation, the functions of the internal organs in the abdominal cavity, perception, and behavioral reactions.
The structures of the central nervous system include:
Seizures are a symptom of epilepsy. Seizures are episodes of disturbed brain function that cause changes in neuromuscular function, attention, or behavior. They are caused by abnormally excited electrical signals in the brain.
Seizures can also be caused by conditions other than epilepsy. Many people experience a single seizure at some point in their life and then never experience another. A single seizure is not considered epilepsy. A single seizure may be related to a specific medical problem such as fever, a reaction to a drug, or withdrawal from alcohol. This situation is different from epilepsy.
Epilepsy is a condition that causes permanent changes in the brain and disturbs how electrical energy works in the brain. The seizures that are associated with epilepsy are provoked by abnormal bursts of electrical activity in the brain.
Until recently, seizures were classified according to the 1981 international classification of seizures proposed by the International League Against Epilepsy (ILAE). In 2017, ILAE released a new classification of seizures that is based on the onset of the seizure (focal or generalized), the state of consciousness during the seizure (aware or impaired awareness), and on the symptoms occurring during the seizure (motor or non-motor.)
Focal seizures are further classified based on the level of awareness for the duration of the seizure as:
Depending on the specific symptoms occurring during the seizure, focal onset seizures are also classified as:
A person with a focal seizure (sometimes known as Jacksonian epilepsy) may not lose consciousness, but may experience jerking movements, convulsions (motor onset), confusion, or odd mental and emotional events (non-motor onset.) Such events may include déjà vu, mild hallucinations, or extreme responses to smell and taste. After the seizure, there is usually temporary muscular weakness. These seizures typically last about 90 seconds.
If awareness is impaired at any point during the seizure, the seizure is considered focal impaired awareness.
Slightly over half of all seizures in adults are the focal impaired awareness type. About 80% of these seizures originate in the temporal lobe, the part of the brain located close to the ear. Temporal lobe disturbances can result in loss of judgment, involuntary or uncontrolled behavior, or loss of consciousness. People may lose consciousness briefly and appear to others as motionless with a vacant stare. Emotions can be exaggerated; some people even appear to be drunk. After a few seconds, a person may begin to perform repetitive movements, such as chewing or smacking of lips. Episodes usually last no more than 2 minutes. They may occur infrequently, or as often as every day. A throbbing headache may follow this type of seizure.
In some cases, focal onset seizures evolve into focal to bilateral tonic-clonic seizures. These resemble generalized tonic-clonic seizures (discussed below.) The progression may be so rapid that the initial focal onset is not even noticed.
Generalized seizures are caused by nerve cell disturbances that occur in more widespread areas of the brain than focal seizures. Therefore, they have more serious effects. Awareness is always impaired during generalized seizures.
Generalized onset seizures are further subcategorized as:
Tonic-Clonic (Grand Mal) Seizures
The first stage of a grand mal seizure is called the tonic phase. The muscles suddenly contract, causing the person to fall and lie stiffly for about 10 to 30 seconds. Some people experience a premonition or aura before a grand mal seizure. Most, however, lose consciousness without warning. If the throat or larynx is affected, there may be a high-pitched musical sound (stridor) when the person inhales.
Spasms occur for about 30 seconds to 1 minute. The seizure then enters the second phase, called the clonic phase. The muscles begin to alternate between relaxation and rigidity. Loss of bowel or urinary control may occur. The seizure usually lasts a total of 2 to 3 minutes. The person remains unconscious for a while and then awakens to confusion and extreme fatigue. A severe throbbing headache similar to migraine may also follow the tonic-clonic phases.
Absence (Petit Mal) Seizures
Absence or petit mal seizures are brief losses of consciousness that occur for 3 to 30 seconds. Physical activity and loss of attention may pause for only a moment. Such seizures may pass unnoticed by others. Young children may simply appear to be staring or walking distractedly. Petit mal may be confused with simple or complex partial seizures, or even with attention deficit hyperactivity disorder (ADHD.) In petit mal, however, a person may experience attacks as often as 50 to 100 times a day.
Myoclonic seizures are a series of brief jerky contractions of specific muscle groups, such as the face or trunk.
Atonic (Akinetic) Seizures
A person who has an atonic (or akinetic) seizure loses muscle tone. Sometimes it may affect only one part of the body so that, for instance, the jaw slackens and the head drops. At other times, the whole body may lose muscle tone, and the person can suddenly fall. A brief atonic episode is known as a drop attack.
Simply Tonic or Clonic Seizures
Seizures can also be simply tonic or clonic. In tonic seizures, the muscles contract and consciousness is altered for about 10 seconds, but the seizures do not progress to the clonic or jerking phase. Clonic seizures, which are very rare, occur primarily in young children, who experience spasms of the muscles but not tonic rigidity.
Epilepsy is also grouped according to a set of common characteristics, including:
A few syndromes and inherited epilepsies are listed below. They do not represent all epilepsies.
Temporal Lobe Epilepsy
Temporal lobe epilepsy is a form of partial (focal) epilepsy, although generalized tonic-clonic seizures may occur with it.
Frontal Lobe Epilepsy
Frontal lobe epilepsy is characterized by sudden violent seizures. Seizures may also produce loss of muscle function, including the ability to talk. In autosomal dominant nocturnal frontal lobe epilepsy, a rare inherited form, seizures often occur during sleep.
Ohtahara Syndrome (Early Infantile Epileptic Encephalopathy)
Ohtahara syndrome occurs before the age of 3 months and is characterized by frequent seizures and severely abnormal electroencephalograms (EEGs) between seizures. It is associated with high mortality and poor developmental outcomes.
West Syndrome (Infantile Spasms)
West syndrome, also called infantile spasms, is a disorder that involves spasms and developmental delay in children within the first year, usually in infants ages 4 to 8 months.
Benign Familial Neonatal Epilepsy
Benign familial neonatal epilepsy (BFNE) are a rare, inherited form of generalized seizures that occur in infancy. BFNE appears to be caused by genetic defects that affect channels that carry potassium in nerve cells.
Juvenile Myoclonic Epilepsy (Impulsive Petit Mal)
Juvenile myoclonic epilepsy, also called impulsive petit mal epilepsy, is characterized by generalized seizures, usually tonic-clonic marked by jerky movements (called myoclonic jerks), and sometimes absence seizures. It usually occurs in younger people ages 8 to 20.
Lennox-Gastaut syndrome is a severe form of epilepsy in toddlers and young children that causes multiple seizures and some developmental disability. It usually involves absence, tonic, and focal seizures.
Myoclonic-astatic epilepsy (MAE) is a combination of myoclonic seizures and astasia (a decrease or loss of muscular coordination), often resulting in the inability to sit or stand without aid.
Progressive Myoclonic Epilepsy
Progressive myoclonic epilepsy is a rare inherited disorder typically occurring in children ages 6 to 15. It usually involves tonic-clonic seizures and marked sensitivity to light flashes.
Landau-Kleffner syndrome is a rare epileptic condition that typically affects children ages 3 to 7. It results in the loss of ability to communicate either with speech or by writing (aphasia.)
Dravet syndrome, also called severe myoclonic epilepsy of infancy, typically occurs due to genetic mutations that are not inherited. Dravet syndrome affects infants in their first year of life. It usually does not respond well to anti-seizure treatment and is associated with a poor prognosis.
Non-epileptic seizures refer to events that resemble epileptic seizures but are not caused by abnormal electrical activity in the brain. Non-epileptic seizures may be physiological or psychological in origin.
Physiologic non-epileptic seizures result from conditions such as sudden drops in blood pressure (syncope), abnormal heart rhythms (cardiac arrhythmia), low blood sugar associated with diabetes (hypoglycemia), or sleep disorders such as narcolepsy. Psychogenic non-epileptic seizures are usually due to emotional trauma or stress.
Febrile seizures are convulsions in children triggered by a high fever. Most febrile seizures occur in young children ages 9 months to 5 years. Simple febrile seizures last for less than 15 minutes and only occur once in a 24-hour period. They are usually an isolated event and not a sign of underlying epilepsy. However, complex febrile seizures, which last longer than 15 minutes and occur more than once in 24 hours, may be a sign of underlying neurologic problems or epilepsy.
Eclampsia is a life-threatening pregnancy complication associated with tonic-clonic seizures. It can result in pregnant women who develop preeclampsia, a condition marked by extremely high blood pressure and excess fluid in the lungs.
A single seizure may be due to causes other than epilepsy, including:
Many people who have a first seizure will never have another seizure, and do not have epilepsy. Still, a health care provider may order a brain imaging test to make sure that epilepsy is not an underlying cause.
Epileptic seizures are triggered by abnormalities in the brain that cause a group of nerve cells in the cerebral cortex (gray matter) to become activated simultaneously. The activation causes sudden and excessive bursts of electrical energy.
A seizure's effect depends in part on the location in the brain where this electrical hyperactivity occurs. Effects range from brief moments of confusion to minor spasms to loss of consciousness. In most cases of epilepsy, the cause is unknown (idiopathic.)
Sodium, potassium, and calcium are ions that are important for brain function. They produce electric charges that must fire regularly in order for a steady current to pass from one nerve cell in the brain to another. If the ion channels that carry them are genetically damaged, a chemical imbalance occurs. This can cause nerve signals to misfire, leading to seizures.
Abnormalities may occur in neurotransmitters, the chemicals that act as messengers between nerve cells. Scientists in epilepsy research have paid particular attention to the neurotransmitter gamma aminobutyric acid (GABA), which helps prevent nerve cells from over-firing.
Some types of epilepsy are inherited conditions where genetics play a factor. Generalized epilepsy seizure types appear to be more related to genetic influences than focal onset seizure epilepsies.
Epilepsy can be caused by many types of diseases or injuries that damage the brain. Head trauma can bring on seizures and epilepsy. Cerebral palsy and other disorders caused by lack of oxygen to the brain during birth are often associated with epilepsy.
Epilepsy can also develop from another medical condition that affects the brain or central nervous system. Examples include:
Epilepsy affects all age groups but is most common in the very young and the very old. The risk is highest in children under the age of 2 and in older adults over age 65. In infants and toddlers, prenatal factors and birth delivery problems are associated with epilepsy risk.
In children age 10 and younger, generalized seizures are more common. In older children, focal seizures are more common.
Males have a slightly higher risk than females of developing epilepsy.
People who have a family history of epilepsy are at increased risk of developing the condition.
People with epilepsy generally have a normal lifespan. However, they are at risk for health complications.
Injuries from falls
Many people with seizures fall, and injuries are common. Although such injuries are usually minor, people with epilepsy have a higher risk for fractures than those without the disorder. Certain medications (phenytoin, carbamazepine) can affect bone hardness or density and increase the risk for fractures.
Household environments, such as the kitchen and bathroom, can be dangerous places for children with epilepsy. Parents should take precautions to prevent burning accidents from stoves and other heat sources. Children with epilepsy should never be left alone when bathing.
Due to the high risk for accidents, people with epilepsy who have seizures that are not controlled by medication are legally restricted from driving. In general, to obtain a driver's license, a health care provider must confirm that a person has been seizure-free for a specific number of months.
People with epilepsy have a much higher risk for drowning than people without this condition. In fact, one study suggested that the drowning risk for people with epilepsy is 15 to 19 times greater than for the general population. People with epilepsy who swim should avoid deep and cloudy water (a clear swimming pool is best), and always swim with a knowledgeable, competent, and experienced companion or at a facility that has a lifeguard on site.
Depression and anxiety are common among people with epilepsy. People with epilepsy have a higher risk for suicide, particularly in the first 6 months following diagnosis. The risk for suicide is highest among people who have epilepsy and an accompanying psychiatric condition, such as depression, anxiety disorder, schizophrenia, or chronic alcohol use. All antiepileptic drugs can increase the risk of suicidal thoughts and behavior. [For more information, see Medications section in this report.]
Children with epilepsy often experience problems with learning, attention focus, and memory retention. Some of these problems are due to the after-effects of seizures. Medication side effects, including fatigue and drowsiness, can also be contributing factors. Problems with learning and memory can affect school performance, and lead to behavioral issues.
Effects on sexual function
Some people with epilepsy experience sexual dysfunction, including erectile dysfunction. These problems may be caused by emotional factors, medication side effects, or a result of changes in hormone levels.
Effects on reproductive health
A woman's hormonal fluctuation can affect the course of her seizures. Estrogen appears to increase seizure activity, and progesterone reduces it. Antiseizure medications may reduce the effectiveness of oral contraceptives.
Epilepsy can pose risks both to a pregnant woman and her fetus. Compared with women without epilepsy, women with epilepsy have increased risk for spontaneous miscarriages, pregnancy, labor and delivery complications, as well as for fetal growth restriction. Some types of anti-epileptic drugs should not be taken during the first trimester because they can cause birth defects. Women with epilepsy who are thinking of becoming pregnant should talk to their health care providers in advance to plan changes in their medication regimen.
Status epilepticus (SE) is a prolonged seizure that is a serious, potentially life-threatening condition. It is a medical emergency. Permanent brain damage or death can result if the seizure is not treated effectively.
The condition is generally defined as continuous seizure activity that lasts for 30 minutes. There are two forms of status epilepticus: generalized convulsive, which involve prolonged seizures, and non-convulsive, which affects behavior and consciousness. About 25% of people who experience status epilepticus have pre-existing epilepsy. Most times however, this condition occurs in people who do not have epilepsy and who have never had a prior seizure.
In people with epilepsy, SE is usually caused by failure to take anticonvulsant medications as directed, or by the abrupt withdrawal from certain medications. In children, over half of SE cases are caused by high fever. In adults without pre-existing epilepsy, causes of SE include stroke, metabolic disorders, drug overdoses, alcohol intoxication or withdrawal, infections, fever, and head trauma.
Although relatively rare, there is a risk for sudden unexplained death in epilepsy (SUDEP). The causes of such events are not fully known, but heart arrhythmias and pauses in breathing (apnea) may be factors in many cases. Your provider can explain if you have specific risk factors for SUDEP and what protective measures can be taken.
The best preventive measure is to take your medication as prescribed. Talk with your provider if you have any concerns about medication side effects or dosages. Do not make any changes to your drug regimen without speaking first with your provider.
The prognosis for epilepsy depends on various factors. In general, people whose epilepsy is well-controlled by medications have an excellent prognosis, and many experience short- or long-term remission from seizures or resolution of epilepsy.
The outlook is best for people whose epilepsy responds to treatment soon after being diagnosed. The longer a person remains free from seizures, the lower the chance of seizure recurrence. Some people are able to reduce or even stop their anti-seizure medications after having no seizures for several years.
Epilepsy is considered resolved if a person has been seizure-free for 10 years and has not taken antiepileptic medications for 5 years. "Resolved" does not necessarily mean that the epilepsy is cured. It implies that a person does not have active epilepsy.
People who tend to have a poorer prognosis include those with chronic, active epilepsy (high frequency of seizures) that does not respond to early treatment. People who have other illnesses in addition to epilepsy (diabetes and heart disease) are also at increased risk for developing other health problems.
Certain types of childhood epilepsy go away or improve with age, usually by the late teens or 20s. The outlook for childhood epilepsy depends in part on the specific epilepsy syndrome. Syndromes such as childhood absence epilepsy have excellent prognosis, with many children outgrowing the syndrome and experiencing remission by their teenage years. Other syndromes, such as juvenile myoclonic epilepsy, can be well-controlled by medication but are likely to be lifelong.
Seizure symptoms vary from person to person. They depend on the part of the brain affected and the type of epilepsy a person has. Most of the time, a seizure is similar to the one that preceded it.
Seizures often have a specific set of symptoms before, during, and after the event.
Before a seizure, people may experience certain warning signs called an aura. They may include:
During a seizure, people may experience:
After a seizure, people may experience:
An epilepsy diagnosis is often made during an emergency visit for a seizure. If a person seeks medical help for a previous or suspected seizure, the health care provider will ask about medical history, including seizure events, and conduct a neurological exam.
The most important diagnostic tool for epilepsy is an EEG. An EEG records and measures brain waves, which reflect the electrical activity of nerve cells in the brain. The procedure is painless. It uses electrodes applied to the scalp to send signals to a special box. A routine EEG takes about an hour.
In some cases, your provider may want you to do an ambulatory EEG using a portable unit that records brain electrical activity from 24 to 72 hours. Another option is video EEG. This test is conducted in a special hospital room where you will be both monitored by EEG and watched by a video camera to evaluate your behavior during a seizure. You will have an IV so that medications can be administered in case of a prolonged seizure.
Other Neuroimaging Tests
A computerized tomography (CT) scan or magnetic resonance imaging (MRI) scan may be ordered for first-time seizures. More advanced imaging tests may be performed for surgery planning and to identify specific areas in the brain associated with seizure activity. These tests include positron emission tomography (PET), single-photon emission computer tomography (SPECT), and magnetoencephalography (MEG.)
A CT (computed tomography) scan is a much more sensitive imaging technique than x-ray, allowing high definition of both the bony structures and the soft tissues. Clear images of organs such as the brain, muscles, joint structures, veins and arteries, as well as anomalies like tumors and hemorrhages may be obtained with or without the injection of contrasting dye.
Conditions that may cause symptoms similar to epilepsy include:
If you see someone have a seizure, remain calm and take the following actions:
You should call 911 if:
Epilepsy is treated with anti-epileptic drugs (AEDs.) For people with severe epilepsy that has not been helped by drugs, surgery or a neurostimulation device may be options.
AEDs are used to prevent recurrent seizures. Drug therapy is not usually recommended after a single initial seizure, unless imaging tests reveal brain injuries or a diagnosed epilepsy syndrome suggests increased risk for recurrence In general, drug therapy is considered after a person has had 2 or 3 seizures.
Preparing to Become Pregnant
Women with epilepsy who are considering pregnancy should talk to their health care providers before they become pregnant. According to guidelines from the American Academy of Neurology and the American Epilepsy Society:
Medication Use During Pregnancy
Women should discuss with their providers the risks of anti-epileptic drugs (AEDs) and the possibility of making any changes in their drug regimen in terms of dosages or prescriptions. According to current guidelines:
If women on AEDs breastfeed they should be aware that some types of AEDs are more likely than others to pass into the breast milk. The following AEDs appear to be the most likely to pass into breast milk in clinically important amounts: Primidone, levetiracetam, and possibly gabapentin, lamotrigine, and topiramate. Valproate does pass into breast milk, but it is unclear if it affects the nursing infant. Carbamazepine and phenytoin are considered generally safe during lactation.
A mother should watch for signs of lethargy or extreme sleepiness in her infant, which could be caused by her medication. Talk with your provider about any concerns you have about breastfeeding and AEDs.
Anti-epileptic drugs (AEDs) include many types of medications but all act as anticonvulsants.
Seizures can often be controlled using a single-drug regimen. A drug is usually started at a low dose and then slowly increased to a higher dose until the seizures are controlled or side effects occur. If a single drug fails to control seizures, other drugs are added on. The specific drugs and whether more than one should be used are determined by various factors, including a person's age and health condition, and the side effect profile of the drug.
During the first few months of therapy, your health care provider will probably order blood tests to check your liver and kidney function and to monitor drug levels and any side effects. You should let your provider know how you are feeling and if you experience any seizures. Be sure to inform your provider of any medications, herbal remedies, or dietary supplements you take. AEDs can interact with many other drugs.
All antiepileptic drugs can increase the risks of suicidal thoughts and behavior (suicidality.) Research has shown that the highest risk of suicide can occur as soon as 1 week after beginning drug treatment and can continue for at least 24 weeks. People who take these drugs should be monitored for signs of depression, changes in behavior, or suicidality.
There are dozens of anti-epileptic drugs. The following are some of the most commonly prescribed.
Valproate sodium (Depacon, generic), valproic acid (Depakene, generic), and divalproex sodium (Depakote, generic) are anticonvulsants that are chemically very similar to each other. (In this report, they are collectively referred to as valproate.) Valproate products are the most widely prescribed anti-epileptic drugs worldwide. They are the first choice for people with idiopathic generalized tonic-clonic epilepsy and are used to prevent nearly all other major seizures as well.
These drugs have a number of side effects that vary depending on dosage and duration. Most side effects occur early in therapy and then subside. The most common side effects are upset stomach and weight gain. Less common side effects include dizziness, hair thinning and loss, and difficulty concentrating.
Serious side effects include:
Carbamazepine (Tegretol, Equetro, Carbatrol, and generic) is used for many types of epilepsy including partial seizures, generalized tonic-clonic (grand mal) seizures, and mixed seizures. A chewable form is available for children.
Common side effects of carbamazepine include dizziness, drowsiness, problems with walking and coordination, nausea, and vomiting.
Carbamazepine can make hormonal forms of birth control less effective. It can also interact with many types of prescription medication.
More serious side effects may include:
Several other drugs, as well as grapefruit, Seville oranges, and tangelos can increase carbamazepine's blood levels and risk of adverse effects.
Phenytoin (Dilantin, generic) is often prescribed as a first-line drug to treat generalized tonic-clonic (grand mal) seizures and complex focal impaired awareness seizures. This drug may be used alone or in combination with other AEDs.
The most common side effects of phenytoin include problems with walking and coordination, slurred speech, confusion, dizziness, trouble sleeping, and tremor.
More serious side effects may include:
Phenobarbital (Luminal, generic), also called phenobarbitone, is a barbiturate anticonvulsant. Primidone (Mysoline, generic) is converted in the body to phenobarbital, and has the same benefits and adverse effects.
Barbiturates may be used to prevent grand mal (tonic-clonic) seizures or focal seizures. They are no longer typically used as first-line drugs, although they may be the initial drug prescribed for newborns and young children.
Many people experience difficulty with side effects. The most common and troublesome side effects or barbiturates are:
When taken during pregnancy, phenobarbital, like phenytoin and valproate, may lead to impaired cognitive function in the child. There is some evidence that phenobarbitol may cause heart problems in the fetus.
Ethosuximide (Zarontin, generic) is used for petit mal (absence) seizures in children and adults who have experienced no other type of seizures. Methsuximide (Celontin), a drug similar to ethosuximide, may be suitable as an add-on treatment for intractable epilepsy in children.
This drug can cause stomach problems, dizziness, loss of coordination, and lethargy. In rare cases, it may cause severe and even fatal blood abnormalities.
Clonazepam (Klonopin, generic) is recommended for myoclonic and atonic seizures that cannot be controlled by other drugs and for Lennox-Gastaut epilepsy syndrome. Although clonazepam can prevent generalized or focal seizures, people generally develop tolerance to the drug, which causes seizures to recur.
People who have had liver disease or acute angle glaucoma should not take clonazepam, and people with lung problems should use the drug with caution. Clonazepam can be addictive, and abrupt withdrawal may trigger status epilepticus. Side effects include drowsiness, imbalance and staggering, irritability, aggression, hyperactivity in children, weight gain, eye muscle problems, slurred speech, tremors, skin problems, and stomach problems.
Lamotrigine (Lamictal, generic) is approved as add-on (adjunctive) therapy for focal (partial) seizures, and generalized seizures associated with Lennox-Gastaut syndrome, in children aged 2 years and older and in adults.
Lamotrigine is also approved as add-on therapy for treatment of primary generalized tonic-clonic (PGTC) seizures, also known as "grand mal" seizures, in children aged 2 years and older and adults. It can also be used as first-line treatment in these cases if sodium valproate is unsuitable. Lamotrigine can be used as a single drug treatment (monotherapy) for adults with partial seizures. Birth control pills lower blood levels of lamotrigine.
Common side effects include dizziness, headache, blurred or double vision, lack of coordination, sleepiness, nausea, vomiting, insomnia, and rash. Although most cases of rash are mild, in rare cases the rash can become very severe. The risk of rash increases if the drug is started at too high a dose or if used in combination with valproate. (Serious rash is more common in young children who take the drug than it is in adults.) Rash is most likely to develop within the first 8 weeks of treatment. Be sure to immediately notify your provider if you develop a rash, even if it is mild.
Lamotrigine may cause aseptic meningitis. Symptoms of meningitis may include headache, fever, stiff neck, nausea, vomiting, rash, and sensitivity to light. Immediately contact your provider if you experience these symptoms.
Gabapentin (Neurontin, generic) is an add-on drug for controlling focal onset seizures in both adults and children.
Side effects include sleepiness, headache, fatigue, and dizziness. Some weight gain may occur. Children may experience hyperactivity or aggressive behavior.
Pregabalin (Lyrica) is similar to gabapentin. It is approved as add-on therapy to treat focal-onset seizures in adults with epilepsy.
Side effects include dizziness, sleepiness, dry mouth, swelling in hands and feet, blurred vision, weight gain, and trouble concentrating may occur.
Topiramate (Topamax, generic) is similar to phenytoin and carbamazepine and is used to treat a wide variety of seizures in adults and children. It is approved as add-on therapy for people with generalized tonic-clonic seizures, focal-onset seizures, or seizures associated with Lennox-Gastaut syndrome. It is also approved as single drug therapy.
Most side effects are mild to moderate and can be reduced or prevented by beginning at low doses and increasing dosage gradually. Common side effects may include numbness and tingling, fatigue, abnormalities of taste, difficulty concentrating, and weight loss. Serious side effects may include acute glaucoma and other eye problems. Tell your provider right away if you have blurred vision or eye pain. If used during pregnancy, topiramate may increase the risk for cleft lip or palate birth defects.
Oxcarbazepine (Trileptal, generic) is similar to phenytoin and carbamazepine but generally has fewer side effects. It is approved as single or add-on therapy for focal onset seizures in adults and for children ages 4 years and older.
Serious side effects, while rare, include Stevens-Johnson syndrome and toxic epidermal necrolysis. These skin reactions cause a severe rash that can be life threatening. Rash and fever may also be a sign of multi-organ hypersensitivity, another serious side effect associated with this drug. Oxcarbazepine can reduce sodium levels (hyponatremia.) Your provider may want to monitor the sodium (salt) level in your blood.
This drug can reduce the effectiveness of birth control pills. Women who take oxcarbazepine may need to use a different type of contraceptive.
Zonisamide (Zonegran, generic) is approved as add-on therapy for adults with partial seizures.
Zonisamide increases the risk for kidney stones. It may reduce sweating and cause a sudden rise in body temperature, especially in hot weather. Other side effects tend to decrease over time and may include dizziness, forgetfulness, headache, weight loss, and nausea.
Levetiracetam (Keppra, generic) is approved both in oral and intravenous forms as add-on therapy for treating many types of seizures in both children and adults.
Side effects tend to occur mostly in the first month. They include sleepiness, dizziness, and fatigue. More serious side effects may include muscle weakness and coordination difficulties, behavioral changes, and increased risk of infections.
Brivaracetam (Briviact), an analogue of levetiracetam, was recently FDA-approved as an add-on therapy for focal seizures in people ages 16 years and older with epilepsy. Brivaracetam has similar side effects as levetiracetam and is currently used as an adjunct therapy option in cases that have not responded well to other AEDs.
Tiagabine (Gabitril) works by increasing the activity of the inhibitory neurotransmitter GABA. Tiagabine is approved as an add-on drug for treating focal onset seizures in adults and children age 12 years and older. It may cause significant side effects including dizziness, fatigue, agitation, and tremor.
Ezogabine (Potiga), a potassium channel opener, is approved for treatment of partial seizures in adults. Ezogabine is used as an add-on (adjunctive) medication. Its most serious side effect is urinary retention. People who take this drug should be monitored for symptoms such as difficulty initiating urination, weak urine stream, or painful urination.
Other side effects may include coordination problems, memory problems, suicidal thoughts and behavior, fatigue, dizziness, and double vision. In 2013, the FDA warned that this drug may cause retina abnormalities, vision loss, and skin discoloration.
Perampanel (Fycompa) is approved as add-on treatment for focal onset seizures with or without secondary generalization in people age 12 years and older. Perampanel is the first in a new class of AEDs for uncontrolled partial epilepsy. It targets the AMPA glutamate receptor, which is involved in seizure activity. Recent studies indicate it may also be useful in the treatment of generalized tonic-clonic seizures.
Perampanel is taken as a once-daily tablet. Common side effects may include dizziness, drowsiness, and fatigue. Perampanel also has a boxed warning to alert about potential risks of serious mood changes and mental disturbances including irritability, aggression, anxiety, and violent thoughts or behaviors.
An effective antiseizure drug. However, due to reports of deaths from liver failure and from a serious blood condition called aplastic anemia, felbamate is recommended only under certain circumstances. They include severe epilepsy, such as Lennox-Gastaut syndrome, or as monotherapy for partial seizures in adults when other drugs fail, and if the benefits of this treatment are considered greater than the substantial risk for very serious adverse reactions noted above.
Vigabatrin has serious side effects, such as vision disturbances and vision loss, and is generally prescribed only in specific cases. It is sometimes given in low doses for children with Lennox-Gastaut syndrome. Vigabatrin is also prescribed as a low-dose oral solution to treat infantile spasms in children ages 1 month to 2 years.
A benzodiazepine drug prescribed as add-on treatment for children with Lennox-Gastaut syndrome. It can cause rare but serious skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis. The risk for these reactions is highest during the first 8 weeks of treatment. While these types of serious skin reactions can occur with other AEDs, they are not usually associated with benzodiazepine drugs.
Cannabidiol (CBD) is a chemical component of the Cannabis sativa plant, commonly known as marijuana. CBD is not responsible for the intoxication (the "high") that comes from marijuana use, which is instead caused by the psychoactive compound tetrahydrocannabinol (THC.)
Medical marijuana has been investigated as a potential therapy for certain severe types of epilepsy that are resistant to treatment with anti-epileptic drugs. In 2018, the FDA approved the cannabidiol (CBD)-containing oral solution drug (Epidiolex) for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. Epidiolex was the first FDA-approved drug that contains a purified drug substance derived from marijuana. Potential side effects of Epidiolex include sleep disorders and liver injury.
Surgery or surgically implanted neurostimulation devices may be options for people with difficult-to-treat epilepsy that cannot be controlled with medications.
Surgery for epilepsy is brain surgery. There are three main types of surgery:
The goal of surgery is to eliminate or at least reduce seizure activity while not causing any functional deficits, such as deterioration of speech or cognitive abilities. Even if surgery is successful, people may still need to take medications for several years following surgery, to help maintain seizure control.
A surgical team will conduct a thorough evaluation prior to any surgery to make sure a person is a good candidate. Various advanced imaging brain scan and mapping techniques are used to provide information on the exact area or areas in the brain that are triggering seizure activity.
It is also important to identify a person's suitability for surgery based on psychological and other medical factors. People with significant psychiatric disorders, or other significant health problems, may not be suitable candidates.
The major areas of the brain have one or more specific functions.
Cortical resection surgery involves removing a small part of the brain. The two types of resection surgery are lobectomy and lesionectomy.
Lobectomy involves removing an entire lobe of the brain. The most common and successful surgical procedure for epilepsy is anterior temporal lobectomy, which is performed when seizures originate in the temporal lobe. (Surgery is not as successful in epilepsies that occur in the frontal lobe.) It involves removing the front portion of the temporal lobe and small portions from the hippocampus and often the amygdala.
The hippocampus is contained in the temporal lobe and is a part of the brain that is involved in memory processing. It is part of the limbic system, which controls emotions. Temporal lobectomy successfully reduces or eliminates seizures in most people but can cause problems with memory and learning.
Lesionectomies are performed to remove damaged or abnormal tissue that is causing seizure activity. These lesions may be congenital (present at birth) such as cortical dysplasia. Lesions may also be due to other acquired conditions such as strokes or head trauma.
Corpus callostomy disconnects the nerve connections between the right and left sides (hemispheres of the brain.) The surgeon cuts into the band of tissue that connects these hemispheres to prevent seizures from becoming generalized and spreading from one side of the brain to the other. However, this procedure does not stop seizures from continuing to occur in one side of the brain.
Children who have extremely severe seizures that originate on only one side of the brain may be candidates for hemispherectomy, provided that the functions of that hemisphere are impaired or likely to become impaired. This is a radical surgical procedure that involves removing a large portion of one side of the brain.
Other types of surgery are currently being investigated as potential therapies, including laser interstitial thermal therapy. This technique ablates the brain tissue responsible for seizures, while minimizing damage to surrounding brain tissue. It has been used especially in cases of mesial temporal epilepsy, but evidence is still needed to evaluate its full safety and efficacy profile.
Electrical stimulation of areas in the brain that affect epilepsy can help many people with refractory epilepsy. Neurostimulators are sometimes called "pacemakers for the brain." In 1997, the FDA first approved vagus nerve stimulation (VNS) for treating people with partial epilepsy whose seizures were not helped by medication. In 2013, the FDA approved a second neurostimulation device, the RNS stimulator. Researchers are continuing to study other types of brain stimulation devices as treatments for epilepsy.
Vagus nerve stimulation (VNS)
Electrical stimulation of the vagus nerve is an accepted therapy for severe epilepsy that does not respond to medication. The two vagus nerves are the longest nerves in the body. They run from the brain stem and down through each side of the neck, and then pass through the esophagus to the gastrointestinal tract. They affect swallowing, speech, and many other functions. They also appear to connect to parts of the brain that are involved with seizures.
The VNS procedure is as follows:
VNS is FDA-approved for people with focal epilepsy and those whose seizures are not helped by medication. According to the most recent guidelines from the American Academy of Neurology, there is weak evidence that VNS may help as added therapy for children with Lennox-Gastaut syndrome, and children and adults with generalized or focal epilepsy. There is also weak evidence that VNS may possibly help improve depression and mood problems in people with epilepsy.
VNS can help reduce seizure frequency and how long seizures last. For side effects, VNS can cause shortness of breath, hoarseness, sore throat, coughing, ear and throat pain, or nausea and vomiting. These side effects can be reduced or eliminated by reducing the intensity of stimulation.
Some studies suggest that the treatment causes adverse changes in breathing during sleep and may cause lung function deterioration in people with existing lung disease. People who have obstructive sleep apnea should be cautious about this procedure. Turning off the VNS (for example before an MRI or surgery) may increase the risk for status epilepticus. (However, VNS may also be helpful for treating status epilepticus in some people.)
Responsive neurostimulation (RNS Stimulator)
The FDA has approved a new type of neurostimulator device called the RNS stimulator. What makes RNS different from VNS is that it is a responsive stimulation system. RNS detects abnormal electrical activity in the brain and responds by sending electrical stimulation. In other words, the device can theoretically help stop seizures before they occur.
The RNS system is approved for adults with focal onset seizures that could not be controlled with two or more anti-epileptic drugs. The RNS Stimulator will not completely eliminate seizures but can help reduce seizure frequency. In clinical trials, the most common side effect was infection at the implant site. People who have an RNS stimulator implanted cannot undergo MRI procedures.
Transcranial magnetic stimulation (TMS)
TMS uses electromagnetic coils to inhibit neurons. The theory is that repetitive low-frequency impulses may reduce cortical excitability and thus improve epilepsy. However, the quality of evidence in studies that evaluate this treatment appeared to be low. There is evidence that rTMS is safe and not associated with any adverse events. Unfortunately the evidence for seizure reduction is still lacking.
Epilepsy is a chronic and usually lifelong condition. However, epilepsy is considered as resolved if a patient is seizure-free for 10 years and not taking seizure medications for the last 5 years. Seizures cannot be prevented by lifestyle changes alone, but people can make behavioral changes that improve their lives and give them a sense of control.
In most cases, there is no known cause for epileptic seizures, but specific events or conditions may trigger them and should be avoided.
Inadequate or fragmented sleep can set off seizures in many people. Using sleep hygiene or other methods to improve sleep may be helpful.
Specific foods are not generally associated with seizures but may have an effect in certain people. If you suspect that a food is a seizure trigger, try keeping a diary of what you eat and when your seizures occurred. Check with your health care provider if certain foods may interact with any medications you are taking.
Alcohol and smoking
Alcohol and smoking should be avoided. Light alcohol consumption does not usually increase seizure activity in people who are not alcohol dependent or sensitive to alcohol. Heavy alcohol use can trigger seizures, as can cigarette smoking.
Visual stimuli, such as flashing lights or regular moving patterns at a high frequency, can trigger seizures in people with photosensitive epilepsy. Avoid exposure to flashing or strobe lights, such as those used in night clubs or discotheques. Seizures have been reported among people who watch cartoons or play video games with rapidly fluctuating colors and quick flashes.
Relaxation methods include deep breathing, biofeedback, and meditation techniques. No strong evidence supports their value on reducing seizures (although some people benefit), but they may be helpful in reducing anxiety.
Exercise is important for many aspects of epilepsy, although it can be problematic. Weight-bearing exercise helps maintain bone density, which can be reduced by some medications. Exercise can help to prevent weight gain, which is a problem with some drugs. Exercise is also helpful for preventing depression and maintaining good emotional and psychological health.
People with epilepsy do need to take certain precautions to exercise safely. These include making sure not to get too hot or tired, which may trigger seizures. They should refrain from sports that might cause injuries to the head.
Swimming is great exercise, but drowning is a serious risk for people with epilepsy. Make sure that you have a companion with you when you go swimming who can recognize the signs of a seizure and knows what to do if you have one. It is also safest to swim at a pool that has a lifeguard on duty.
The ketogenic diet is very high in fat (90%), very low in carbohydrates, and low in protein. It appears to be helpful for many children with severe epilepsy. Some children who try the ketogenic diet are able to stop or at least reduce their medications.
It is not clear how the ketogenic diet works. The standard theory is that burning fat instead of carbohydrates causes an increase in ketones (chemical substances in the body that result from the breakdown of fat in the body). When excessive levels of ketones are produced, a metabolic state called ketosis happens. Ketosis appears to alter certain amino acids in the brain and to increase levels of the neurotransmitter gamma aminobutyric acid (GABA), which helps prevent nerve cells from over-firing.
This diet must be professionally monitored. Parents can endanger their children if they try the program on their own without consulting a doctor or trained dietician.
The child fasts for the first 1 to 2 days, and then the diet is gradually introduced. The regimen uses small amounts of carbohydrates and large amounts of fats (up to 90%), with very few proteins and no sugar. Children generally consume 75% of their usual daily calorie requirements.
A typical dinner may include a chicken cutlet or piece of fish, broccoli with cheese, lettuce with mayonnaise, and a whipped cream sundae. Vegetables may include celery, cucumbers, or asparagus, cauliflower, and spinach. Breakfast might consist of an omelet, bacon, and cocoa with cream. (Artificial sweeteners are used for any desserts.)
The diet is very complex and difficult, as a slight deviation from the diet can provoke a seizure. Children cannot take medications that contain sugar (which is common in many drugs produced for children.) Some sunscreens and lotions contain sorbitol, a carbohydrate that can be absorbed through skin. Many children and parents find the diet too difficult or ineffective and stop it within 6 months.
Researchers are investigating a modified version of the popular Atkins diet, which does not require the caloric, protein, or fluid restrictions of the ketogenic diet. Unlike the traditional Atkins diet, the modified Atkins diet uses less carbohydrates and fatter intake. Another alternative is a low glycemic index diet, which contains even fewer carbohydrates than the Atkins diet. Still, parents should not put their children on these diets without support from a provider.
Side Effects and Complications
To prevent serious side effects, children need regular monitoring by a provider, especially when the ketogenic diet is first initiated.
Side effects or complications that may occur at the start of the diet include:
Side effects that may occur later on include:
Because most children remain on the diet for only 2 years, the risks for potential long-term damage appear minimal.
Many people with epilepsy and their family members can benefit from support associations. These services are usually free and available in most cities.
People with epilepsy often contend with depression and other mental health issues. Psychological therapy may be helpful. Cognitive behavioral therapy offers a structured counseling program that helps people change behaviors associated with seizure triggers, such as anxiety and insomnia.
Tips for helping children
Some of the following tips may help children with epilepsy:
Abou-Khalil BW, Gallagher ML, Macdonald RL. Epilepsies. In: Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL, eds. Bradley's Neurology in Clinical Practice. 7th edition. Philadelphia, PA: Elsevier; 2016:chap 101.
Bates K. Epilepsy: current evidence-based paradigms for diagnosis and treatment. Prim Care. 2015;42(2):217-232. PMID: 25979583 www.ncbi.nlm.nih.gov/pubmed/25979583.
Bhatia R, Bevan C, Gerard EE. Neurologic disorders in pregnancy. In: Landon MB, Galan HL, Eric R.M. Jauniaux ERM, et al, eds. Gabbe's Obstetrics: Normal and Problem Pregnancies. 8th edition. Philadelphia, PA: Elsevier; 2021:chap 54.
Chen R, Spencer DC, Weston J, Nolan SJ. Transcranial magnetic stimulation for the treatment of epilepsy. Cochrane Database Syst Rev. 2016;(8):CD011025. PMID: 27513825 www.ncbi.nlm.nih.gov/pubmed/27513825.
Fisher RS. The new classification of seizures by the International League Against Epilepsy 2017. Curr Neurol Neurosci Rep. 2017;17(6):48. PMID: 28425015 www.ncbi.nlm.nih.gov/pubmed/28425015.
Gavvala JR, Schuele SU. New-onset seizure in adults and adolescents: a review. JAMA. 2016;316(24):2657-2668. PMID: 28027373 www.ncbi.nlm.nih.gov/pubmed/28027373.
Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48-61. PMID: 26900382 www.ncbi.nlm.nih.gov/pubmed/26900382.
Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018;91(2):74-81. PMID: 29898971 www.ncbi.nlm.nih.gov/pubmed/29898971.
Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018;91(2):82-90. PMID: 29898974 www.ncbi.nlm.nih.gov/pubmed/29898974.
Krishnamurthy KB. Epilepsy. Ann Intern Med. 2016;164(3):ITC17-ITC32. PMID: 26829918 www.ncbi.nlm.nih.gov/pubmed/26829918.
Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015;84(16):1705-1713. PMID: 25901057 www.ncbi.nlm.nih.gov/pubmed/25901057.
Manford M. Recent advances in epilepsy. J Neurol. 2017;264(8):1811-1824. PMID: 28120042 www.ncbi.nlm.nih.gov/pubmed/28120042.
Markle M, Nativio DG. Medical marijuana in the pediatric population with epilepsy - what you should know. J Pediatr Health Care. 2019;33(6):626-632. PMID: 31160106 www.ncbi.nlm.nih.gov/pubmed/31160106.
Martin-McGill KJ, Jackson CF, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2018;11:CD001903. PMID: 30403286 www.ncbi.nlm.nih.gov/pubmed/30403286.
Mikati MA, Tchapyjnikov D. Seizures in childhood. In: Kliegman RM, St Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of Pediatrics. 21th ed. Philadelphia, PA: Elsevier; 2020:chap 611.
Morris GL 3rd, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;81(16):1453-1459. PMID: 23986299 www.ncbi.nlm.nih.gov/pubmed/23986299.
Prince E, Hakimian S, Ko AL, Ojemann JG, Kim MS, Miller JW. Laser interstitial thermal therapy for epilepsy. Curr Neurol Neurosci Rep. 2017;17(9):63. PMID: 28699085 www.ncbi.nlm.nih.gov/pubmed/28699085.
Russell K, Cahill M, Duderstadt KG. Medical marijuana guidelines for practice: health policy implications. J Pediatr Health Care. 2019;33(6):722-726. PMID: 31655786 www.ncbi.nlm.nih.gov/pubmed/31655786.
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512-521. PMID: 28276062 www.ncbi.nlm.nih.gov/pubmed/28276062.
Stephen LJ, Harden C, Tomson T, Brodie MJ. Management of epilepsy in women. Lancet Neurol. 2019;18(5):481-491. PMID: 30857949 www.ncbi.nlm.nih.gov/pubmed/30857949.
Thijs RD, Surges R, O'Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393(10172):689-701. PMID: 30686584 www.ncbi.nlm.nih.gov/pubmed/30686584.
Wiebe S. The epilepsies. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier Saunders; 2020:chap 375.
West S, Nolan SJ, Cotton J, et al. Surgery for epilepsy. Cochrane Database Syst Rev. 2015;(7):CD010541. PMID: 26130264 www.ncbi.nlm.nih.gov/pubmed/26130264.
Reviewed By: Amit M. Shelat, DO, FACP, FAAN, Attending Neurologist and Assistant Professor of Clinical Neurology, Stony Brook University School of Medicine, Stony Brook, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.